Related Experiment Video

Updated: May 22, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

Epidemiology and management of Kawasaki disease

Nadia J C Luca1, Rae S M Yeung

  • 1Department of Pediatrics, University of Toronto, Toronto, ON, Canada.

Drugs
|May 25, 2012
PubMed

Insights

Kawasaki disease (KD) is a serious childhood vasculitis. Standard treatment with aspirin and IVIG reduces heart risks, but further research is needed for complex cases and complications.

Area of Science:

  • Pediatric Rheumatology
  • Cardiology
  • Immunology

Background:

  • Kawasaki disease (KD) is an acute systemic vasculitis impacting children globally.
  • It is a leading cause of acquired heart disease in pediatric populations.
  • KD incidence is increasing, particularly in children under five, males, and those of Asian descent.

Purpose of the Study:

  • To summarize current understanding and management of Kawasaki disease.
  • To highlight the role of standard and emerging treatments.
  • To emphasize awareness of acute complications.

Main Methods:

  • Review of existing literature on Kawasaki disease diagnosis and treatment.
  • Analysis of standard therapeutic approaches, including aspirin and IVIG.
  • Discussion of evidence for managing refractory cases and complications.

Main Results:

  • High-dose aspirin (acetylsalicylic acid; ASA) and intravenous immune globulin (IVIG) are effective in preventing coronary artery aneurysms.
  • Anticoagulation plays a role, though evidence-based guidelines are limited.
  • Refractory KD management involves immunosuppressants like corticosteroids and TNF-α inhibitors.

Conclusions:

  • Standard KD treatment effectively mitigates coronary artery issues.
  • Further research is essential for optimizing management of refractory disease and acute complications like myocarditis and macrophage activation syndrome.
  • Prompt recognition and management are crucial for favorable outcomes in Kawasaki disease.

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...